Comprehensive Veterinary Pharmacovigilance Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Veterinary Pharmacovigilance Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for veterinary pharmacovigilance has seen significant growth in the past few years. The projected growth is from $0.81 billion in 2024 to an estimated $0.91 billion in 2025, marking a compound annual growth rate (CAGR) of 13.1%. Factors contributing to this growth in the past period include a growing consciousness about the health of animals, an increase in the companion animal population, a high demand for livestock products, development in veterinary services, and an increased presence of zoonotic illnesses.

Veterinary Pharmacovigilance Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, a swift expansion is forecasted for the veterinary pharmacovigilance market. It is projected to reach a worth of $1.48 billion in 2029, with a compound annual growth rate (CAGR) of 12.9%. The predicted surge within the projection period can be associated with various factors like the rise in pet adoption and expenditure, elevated veterinary spending, heightened attention to animal welfare, expansion of telemedicine within veterinary services, and an increased requirement for personalized veterinary care. The projection period is also likely to witness key trends such as the utilization of digital reporting systems, expansion of telehealth facilities for veterinary care, incorporation of blockchain for data protection, and creation of cloud-based pharmacovigilance platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-pharmacovigilance-global-market-report

What Are the Drivers Transforming the Veterinary Pharmacovigilance Market?
The veterinary pharmacovigilance market is predicted to expand due to the increasing demand for animal health and medicinal products. These products, which include food, medications, and grooming items, aim at ensuring the health and well-being of pets. Factors such as the increasing number of pet owners, advancements in veterinary medicine, and the requirement for enhanced livestock productivity are driving this growing demand. Moreover, the rise in awareness of animal welfare, combined with a higher prevalence of animal diseases, fuels this surge in demand. By monitoring and assessing the adverse effects of pet medications and ensuring regulatory compliance, veterinary pharmacovigilance plays a crucial role in pet care. To illustrate, the Republic of Estonia's Agency of Medicines (Ravimiamet), a national regulatory authority based in Estonia, reported that the veterinary medicinal products sector grew by 6.9% in 2023, hitting 18.6 million euros, a growth from 17.4 million euros in 2022. Hence, the rising demand for animal health and medicinal products will catalyze the expansion of the veterinary pharmacovigilance market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21002&type=smp

What Long-Term Trends Will Define the Future of the Veterinary Pharmacovigilance Market?
Key players in the veterinary pharmacovigilance market are concentrating on expanding and reinforcing regulatory frameworks through progressing data analytics, which includes adverse event reporting (REAS) and safety report creation. These processes involve the recording and examination of detrimental reactions to veterinary drugs, to guarantee their safety, effectiveness, and compliance with regulatory norms. For example, in August 2024, the Mexico-based governmental body, Ministry of Agriculture and Rural Development, introduced a veterinary pharmacovigilance system. This system, developed by SENASICA, monitors the safety, quality, and efficacy of veterinary drugs in Mexico by collecting data related to adverse reactions from various sources including pharmaceutical companies, distributors, and veterinary hospitals. It is aimed to identify, evaluate, and control the risks linked to these drugs. The system also utilizes the veterinary pharmacovigilance guide (REAS) to document adverse reactions and monitor effectiveness, residue limit compliance, and environmental concerns.

Which Segments in the Veterinary Pharmacovigilance Market Offer the Most Profit Potential?
The veterinary pharmacovigilance market covered in this report is segmented -

1) By Type: In House, Outsourced
2) By Solution: Software, Services
3) By Product: Biologics, Anti Infectives, Other Products
4) By Animal Type: Companion Animals, Livestock Animals, Other Animal Types
5) By End User: Veterinary Hospitals, Veterinary Companies, Academic And Research Institutes

Subsegments:
1) By In House: Internal Pharmacovigilance Departments, In-House Monitoring And Reporting Systems, Veterinary Adverse Event Management Software
2) By Outsourced: Third-Party Pharmacovigilance Services, Contract Research Organizations (CROs) For Pharmacovigilance, Pharmacovigilance Consulting And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21002&type=smp

Which Firms Dominate the Veterinary Pharmacovigilance Market by Market Share and Revenue in 2025?
Major companies operating in the veterinary pharmacovigilance market are accenture* PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Santé Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group

Which Regions Offer the Highest Growth Potential in the Veterinary Pharmacovigilance Market?
North America was the largest region in the veterinary pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21002

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.